Skip to main
BWAY

Brainsway (BWAY) Stock Forecast & Price Target

Brainsway (BWAY) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrainsWay is poised for continued growth as a leader in TMS commercialization due to its innovative technology and strategic investments in mental health networks. With 11 consecutive quarters of profitability and expected growth through 2026, the company has a solid financial foundation and potential for expansion into new indications and partnerships. While competition and regulatory challenges may pose risks, BrainsWay's strong market demand and successful business strategy suggest a positive outlook for the company.

Bears say

BrainsWay is positioned for long-term success due to its strong financial performance, growing recurring revenue model, and expanding market opportunities, including the anticipated commercial entry of COMP360 psilocybin therapy. Additionally, the company's intellectual property portfolio and real-world evidence support the effectiveness of its Deep TMS platform technology. While competition from alternative therapies may arise, the continued support from key investors like Valor Equity Partners provides a solid foundation for future growth and success.

Brainsway (BWAY) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brainsway (BWAY) Forecast

Analysts have given Brainsway (BWAY) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Brainsway (BWAY) has a Strong Buy consensus rating as of Aug 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brainsway (BWAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.